IFN-α can increase triglyceride levels and induce hepatic steatosis by upregulating the expression level of acyl-CoA synthetase long chain family member 1, which indirectly promotes HBsAg clearance in patients with CHB (129). This evidence concerns the gene IFNA1 and fatty liver disease.